You are here: Industry Insights > Molnupiravir

News List

Progress of Research on Key COVID-19 Treatments Deborah Seah
December 17, 2021
At the point of writing the COVID-19 pandemic is nearing its two-year run with more than four million deaths and a total of 219 million cases worldwide. Scientists across the world are still scrambling to better understand...
Merck and Ridgeback make pact with UNICEF for antiviral COVID-19 medicine supply CPhIonline
January 20, 2022
The agreement will enable millions of patients in more than 100 low- and middle-income countries to gain access to molnupiravir.
Beximco Pharma to manufacture molnupiravir for COVID-19 pharmatimes
January 20, 2022
The drug received conditional marketing authorisation in the UK from the MHRA in November
Merck, Ridgeback Ink Molnupiravir Supply Agreement with UNICEF contractpharma
January 18, 2022
Allocate 3 million courses of the oral antiviral to be provided in first half of 2022 for use in low- and middle-income countries.
India to become hub for COVID-19 antiviral generic drugs: Fitch ExpressPharma
January 10, 2022
India will become the largest global hub for COVID-19 antiviral general drug production after the drug controller granted Emergency Use Authorisation (EUA) to several pharmaceutical companies in the country to manufacture...
Aurobindo Pharma rolls out Molnaflu to treat adult COVID-19 patients ExpressPharma
January 07, 2022
The pill is available pan-India across all major metros and towns
Entod Pharmaceuticals set to launch Molentod for treating COVID-19 ExpressPharma
January 06, 2022
Entod Pharmaceuticals today said that it is launching a generic version of Molnupiravir under the brand Molentod in India.
Dr Reddy’s to launch generic COVID-19 Merck drug at about 50 cents a pill ExpressPharma
January 05, 2022
Dr Reddy’s Laboratories will launch its generic version of Merck’s antiviral COVID-19 pill, Molnupiravir, and price it at Rs 35 ($0.4693) per capsule, a company spokesperson said yesterday.
Health ministry approves Corbevax, Covovax and Molnupiravir for restricted use in emergency situation ExpressPharma
December 29, 2021
The government yesterday announced that it has approved emergency use of two more COVID-19 vaccines and anti-viral drug Molnupiravir.
FDA authorizes additional oral antiviral for treatment of COVID-19 in certain adults WorldPharmaNews
December 28, 2021
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Merck's molnupiravir for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults with positive results of direct SARS-CoV-2 viral testing...

Previous page 1 2 3 4 Next page